Swift Medical
Digital wound care platform that uses calibrated wound images, AI-supported analysis, workflow software, and analytics to standardize wound assessment and documentation.
Last updated: June 6, 2026
Back to directoryAI dermatology image-search tool that analyzes submitted skin photos and returns relevant disease information rather than a definitive diagnosis.
Educational, triage-adjacent, or clinician-reviewed image-search workflows where outputs are treated as reference material and not diagnosis.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Model Dermatol as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as medical information retrieval unless local deployment changes the intended use; verify CE MDR Class I marking, FDA non-approval, diagnostic disclaimers, app-store labeling, and country-specific medical-device rules before clinical use. |
|---|---|
| Privacy | Review image upload, metadata fields, symptoms, language and country processing, device information, transfer for analysis, no-storage claims, consent, and whether organizational use needs a separate agreement. |
| Evidence | Use published algorithm and research materials as background only, then test local cases for image quality, skin tone, condition mix, false reassurance, and whether reference links support safe next steps. |
| Workflow | Best governed as an educational or clinician-reviewed visual search aid with explicit escalation to dermatology or urgent care for concerning lesions, changing symptoms, or uncertain outputs. |
Model Dermatology describes Model Dermatol as an AI dermatology image-search tool for finding relevant skin disease information, states that it is freely available on Android, iOS, and PCs, and says it should not be used as a medical device for diagnosis. Its privacy policy says submitted cropped images and metadata are transferred for analysis but not stored, and the site states the algorithm has CE MDR Class I marking but no FDA approval.
Not for: Emergency skin findings, autonomous diagnosis, replacing dermatology review, biopsy decisions, or regulated clinical use in settings where FDA clearance or local authorization is required.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.